BioHealth News Archive
States would be wise to emulate New York health accelerator model – FierceMobileHealthcare
It was exciting to see the creation this week of the New York Digital Health Accelerator in New York. The New York State Department…
Read More
BioHealth Innovation, Inc. Appoints Qiagen’s Douglas Liu to Board of Directors
BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced…
Read More
Foundation Seeks Help Identifying Innovators in Vaccine Delivery | Bill & Melinda Gates Foundation
The Bill & Melinda Gates Foundation is now accepting nominations for the second annual Gates Vaccine Innovation Award. The award aims to recognize, celebrate,…
Read More
Healthcare execs to mentor digital startups in NY ‘accelerator’ program
In a move that combines an interest in improving health outcomes with a desire to create jobs and boost the state economy, the New…
Read More
AstraZeneca CEO to retire amidst double digit losses
David Brennan's move to retire as AstraZeneca's (NYSE:AZN) CEO in June did not come as a surprise to those who had been urging for a…
Read More
NATIONAL BIOECONOMY BLUEPRINT
“The world is shifting to an innovation economy and nobody does innovation better than America.” —President Obama, December 6, 2011 Economic activity that is…
Read More
Drug research: All together now | The Economist
IT WAS once only drug firms that developed drugs. But this is changing. Take the case of the Michael J. Fox Foundation, a Parkinson’s…
Read More
Nodality loses leader to NEA as medical diagnostics model morphs – San Francisco Business Times
Growing diagnostic test developer Nodality Inc. is losing its first CEO, but the venture capital world is gaining another experienced life sciences entrepreneur. Dr.…
Read More
Zyngenia, Inc. Recruits David Parkinson, M.D., as Board Member, Clinical Advisory Board Head, and Interim Chief Medical Officer
Zyngenia, Inc., a biopharmaceutical company developing Zybodies(TM), next-generation multi-specific antibody-based drugs in oncology and immunology, announced today that it has appointed David Parkinson, M.D.…
Read More
University of Maryland BioPark Announces MedImmune’s Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
BALTIMORE, MARYLAND, April 24, 2012 – The University of Maryland BioPark announced today thatBahija Jallal, Ph.D., Executive Vice President of Research and Development at…
Read More
Human Genome Sciences cuts losses – Washington Business Journal
Rockville-based Human Genome Sciences Inc., which last week rejected an unsolicited $2.6 billion acquisition offer by GlaxoSmithKline PLC, reported higher revenue and cut losses…
Read More
Maryland 12th in Venture Capital Dollars in First Quarter
Venture capital dollars flowing to Maryland companies were down almost 30 percent last quarter compared to a year ago, and 16 percent less than…
Read MoreMaryland Establishes New Tech Transfer Fund
The state and five universities are spending upwards of $5.8 million to help startups move from a concept to a company. Senate Bill 239/House Bill 442…
Read More
Genome entrepreneurs say their data will help you live longer | VentureBeat
The cost of sequencing the human genome continues to fall, reaching a low of $1,000 this year due to a new microchip and machine…
Read More
Supernus Pharmaceuticals readies D.C. region’s first biotech IPO since 2007 – Washington Business Journal
Supernus Pharmaceuticals Inc. is slated to go public this week, more than a year after first filing paperwork to list its stock on the…
Read More